Drug Discovery · Waltham, MA · Founded 2017 · Out of Business
Developer of a biotechnology product platform designed to deliver chemotherapy directly to tumors through antibody-drug conjugates. Mythic Therapeutics is based in Waltham, MA and was founded in 2017. Its last known valuation is $293 million (Dec 2021). It has raised $156 million across 4 recorded rounds; the latest was a $29.9 million early-stage round in Dec 2024.
Last price · $/share
—
Implied valuation
$293.0M
Total raised
$156.5M
Last round
Early Stage VC
Dec 2024
Cap table — not yet on record
Mythic Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mythic Therapeutics with a free account
·The complete investor list: 17 names
·Watch Mythic Therapeutics: the Monday email on marks, rounds and moves
Where does Mythic Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Mythic Therapeutics's 4 recorded funding rounds.
